Medical Devices

Public Workshop – Hemostatic Medical Devices for Trauma Use, September 3-4, 2014

The Food and Drug Administration (FDA) is announcing a public Workshop entitled: “Hemostatic Medical Devices for Trauma Use”. The purpose of the workshop is to obtain information on the current challenges and opportunities related to Hemostatic Medical Devices for use in emergency situations. Workshop participants will discuss factors that contribute to hemostatic medical device performance, reliability, and the types of studies that could potentially be used to evaluate appropriate bench testing, animal testing, bleeding severity, human factors, and clinical data collection for these products.

In advance of the workshop, CDRH invites interested stakeholders to submit protocols which describe procedures to evaluate issues (e.g., design, validation, conduct, and analysis) related to the adequacy of the above mentioned studies. Of particular interest are methods for assessing high-risk products used in non-compressible wound hemorrhage. These protocols will be reviewed by CDRH in order to determine viable solutions and paradigms for assessing the safety and effectiveness of hemostatic devices based on scientifically supported expert stakeholder opinions. Results of the review will be incorporated into the workshop for in-depth discussion and consensus, potentially leading to guidance from the Agency.

Deadline for submitting protocols has been extended to June 27, 2014.


Date, Time and Location:

This meeting will be held September 3-4, 2014, beginning at 8:00 a.m. (EDT) at the following location:

FDA White Oak Campus
10903 New Hampshire Avenue
Bldg. 31, Room 1503A (Section A of the Great Room)
Silver Spring, MD, 20993

FDA Campus Information

Back to Top Arrow


Agenda

Wednesday, September 3, 2014

7:30am - 8:00am Onsite Registration

Day 1: Landscape and Challenges

8am - 8:10am Welcome Remark - Binita Ashar, MD (FDA)
8:10am - 8:30am Keynote Address - COL Todd Rasmussen

Session I - Landscape

Objective:  Gain an understanding of the regulatory pathways for hemostatic medical devices with indications for trauma use, and their current operational environments.

8:30am - 9:10am FDA Landscape and Regulatory Paths
Speakers: David Krause, PhD (Surgical Devices, CDRH), Kenneth Cavanaugh, PhD (Cardiovascular Devices, CDRH), Nisha Jain, MD (CBER), Nicole Verdun, MD (CDER)
9:10am - 9:55am End User Perspectives of Currently Marketed Products
Speakers: LTC David King (Military Perspective), Rick Alcorta, MD (First Responder Perspective), John Holcomb, MD (Civilian Trauma Perspective)
9:55am - 10:10am Panel Discussion - Moderator: Howard Champion, MD
10:10am - 10:25am Break

Session II - Unmet Trauma Care Needs

Objective:  Gain an understanding of the unmet needs in the military and civilian communities in terms of types of injuries, operational challenges, translational research, use of existing data, and clinical data collection hurdles.

10:25am - 11:10am Military Unmet Needs
Speakers: Tony Pusateri, PhD (MRMC), David Marcozzi, MD (USARMY), LTC David King (USARMY)
11:10am - 12:00pm Civilian Unmet Needs
Speakers: Tim Emhoff, MD (Surgery - Trauma), Rick Alcorta, MD (EMS), Tom Scalea, MD (Shock Trauma), Jason Sperry, MD (Prehospital studies)
12:00pm - 1:00pm Lunch
1:00pm - 2:00pm How can we get more data?
Speakers: Kevin Prohaska, MD (FDA), John Holcomb, MD (Civilian Trauma Studies), COL Todd Rasmussen (DoDTR), Ben Eloff, PhD (FDA and Data Registries)
2:00pm - 2:30pm Panel Discussion - Binita Ashar, MD (FDA)
2:30pm - 2:45pm BREAK

Session III - Assessing Safety and Effectiveness

Objective: Gain an understanding of the types of novel products being developing and their challenges with target patient populations, regulatory strategies and human factors consideration.

2:45pm - 3:45pm Industry Perspectives
Speakers: Lance Hopman, MS (SAM Medical), David Spencer, BS (Pryor Medical), George Falus, PhD and Grant Bochicchio, MD (Biomedica), Upma Sharma, PhD (Arsenal),
3:45pm - 3:55pm Human Factors Considerations - Ron Kaye, MA (FDA)
3:55pm - 4:20pm Panel Discussion – Moderator: Andrew Barofsky, JD (RevMedX)
Additional Panel Participants: T.S. Sudarshan, PhD (Materials Modification), Maynard Ramsey, MD PhD (CardioCommand), Allison Kumar, BS (FDA), David Krause, PhD (FDA), Rick Alcorta, MD (EMS), and Military Representative
4:20pm - 4:30pm Day 1 Recap, Set Stage for Day 2, Adjourn

Thursday, September 4, 2014

7:30am - 8:00am Onsite Registration
8:00am - 8:05am Welcome Remark - Binita Ashar, MD (FDA)
8:05am - 8:50am Keynote Address - Bijan Kheirabadi, PhD (USAISR)

Session IV - Challenges in Evaluation and Validation

Objective:  Gain an understanding of the advances in pre-clinical bench testing, the various translational animal models and other novel studies.

8:50am – 10:15am Thinking Outside the Box: Pre-clinical Testing
Speakers:  LTC David King (USARMY), Maynard Ramsey, MD PhD (CardioCommand), T.S. Sudarshan, PhD (Materials Modification), Adam Rago, BS (Arsenal), Peter Kofinas, PhD (University of Maryland-Academia), Charles Durfor, PhD (FDA)
10:15am - 10:45am Panel Discussion - Moderator:  Joshua Crist, MSE (FDA)
Additional Panel Participants: Bijan Kheirabadi, PhD (USAISR), Adam Rago, BS (Biomedica), Keith Hoots, MD (NHLBI), Karen Manhart-Byrnes, VMD (FDA)
10:45am – 11:00am BREAK

Session V - Case Study: XSTAT's Regulatory Journey

11:00am - 11:35am Andrew Barofsky, JD (RevMedX), Military Representative, Joshua Crist, MSE (FDA) and FDA Representative discuss the regulatory pathway and challenges met along the way
11:35am - 11:45am Q&A
Additional Participant: David Krause, PhD (FDA)

Session VI - Interactive Solutions

11:45am - 12:30pm Workshop participants will work in focus groups to collaboratively propose answers to key questions raised during the course of the workshop and suggest next steps and prioritization to FDA.
Moderator: Allison Kumar, Sr. Program Manager / Military Liason (FDA)
12:30pm Workshop Adjourns

Back to Top Arrow


Registration to Attend the Workshop

Registration is closed as of August 22, 2014. Onsite registration will be available.

Back to Top Arrow


Webcast

This public workshop will also be Webcast. Persons interested in viewing the Webcast must register online by 4 p.m. on August 22, 2014. Organizations are requested to register all participants, but to view using one connection per location.

Webcast participants will be sent technical system requirements after registration and will be sent connection access information after August 26, 2014. If you have never attended a Connect Pro event, test your connection at https://collaboration.fda.gov/common/help/en/support/meeting_test.htm. To get a quick overview of the Connect Pro program, visit: http://www.adobe.com/go/connectpro_overview.

If you require special accommodations due to a disability, or need additional information regarding registration, please contact Susan Monahan, Office of Communication and Education, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Bldg. 66, Silver Spring, MD 20993, 301-796-5661, susan.monahan@fda.hhs.gov.

Back to Top Arrow


Contact

For questions regarding workshop content please contact:

Maegen Colehour
Center for Devices and Radiological Health, Food and Drug Administration
10903 New Hampshire Ave., Bldg. 66 Rm. G423
Tel: 301-796-6970, Email: Maegen.Colehour@fda.hhs.gov

Or

Allison Kumar
Center for Devices and Radiological Health, Food and Drug Administration
0903 New Hampshire Ave., Bldg. 66
Tel: 301-796-6369, Email: Allison.Kumar@fda.hhs.gov

Back to Top Arrow

Page Last Updated: 08/27/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.